NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Photocure ASA (OL: PHO)
PHO Technical Analysis
1.5
As on 22nd Nov 2024 PHO STOCK Price closed @ 48.40 and we RECOMMEND Sell for LONG-TERM with Stoploss of 54.60 & Buy for SHORT-TERM with Stoploss of 46.24 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PHOSTOCK Price
Open | 49.65 | Change | Price | % |
High | 50.00 | 1 Day | -1.25 | -2.52 |
Low | 48.30 | 1 Week | -4.40 | -8.33 |
Close | 48.40 | 1 Month | -2.80 | -5.47 |
Volume | 80134 | 1 Year | -1.60 | -3.20 |
52 Week High 70.90 | 52 Week Low 40.85 |
OL Norway Most Active Stocks
EAM | 0.17 | 6.25% |
AOW | 2.00 | -5.21% |
SHLF | 10.20 | -20.13% |
ASA | 0.08 | 0.00% |
ENSU | 0.83 | -5.68% |
NEL | 2.96 | 1.37% |
IDEX | 0.13 | 0.00% |
NHY | 71.48 | -0.50% |
RECSI | 4.29 | 6.98% |
SATS | 23.95 | -3.62% |
OL Norway Top Gainers Stocks
OL Norway Top Losers Stocks
PHO Daily Charts |
PHO Intraday Charts |
Whats New @ Bazaartrend |
PHO Free Analysis |
|
PHO Important Levels Intraday
RESISTANCE | 51.68 |
RESISTANCE | 50.63 |
RESISTANCE | 49.98 |
RESISTANCE | 49.33 |
SUPPORT | 47.47 |
SUPPORT | 46.82 |
SUPPORT | 46.17 |
SUPPORT | 45.12 |
PHO Forecast November 2024
4th UP Forecast | 67.86 |
3rd UP Forecast | 61.62 |
2nd UP Forecast | 57.76 |
1st UP Forecast | 53.9 |
1st DOWN Forecast | 42.9 |
2nd DOWN Forecast | 39.04 |
3rd DOWN Forecast | 35.18 |
4th DOWN Forecast | 28.94 |
PHO Weekly Forecast
4th UP Forecast | 56.69 |
3rd UP Forecast | 54.03 |
2nd UP Forecast | 52.39 |
1st UP Forecast | 50.74 |
1st DOWN Forecast | 46.06 |
2nd DOWN Forecast | 44.41 |
3rd DOWN Forecast | 42.77 |
4th DOWN Forecast | 40.11 |
PHO Forecast2024
4th UP Forecast | 108.52 |
3rd UP Forecast | 89.24 |
2nd UP Forecast | 77.32 |
1st UP Forecast | 65.4 |
1st DOWN Forecast | 31.4 |
2nd DOWN Forecast | 19.48 |
3rd DOWN Forecast | 7.56 |
4th DOWN Forecast | -11.72 |
Photocure ASA ( OL Norway Symbol : PHO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PHO Other Details
Segment | EQ | |
Market Capital | 3226202112.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
PHO Address
PHO Latest News
PHO Business Profile
Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, other European Countries, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to license partners, pharmaceutical wholesalers, pharmacies, and hospitals. Photocure ASA was founded in 1997 and is headquartered in Oslo, Norway. Address: Hoffsveien 4, Oslo, Norway, 0275
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service